Skip to main content
. Author manuscript; available in PMC: 2020 Sep 16.
Published in final edited form as: Ann Intern Med. 2017 Jul 11;167(4):228–235. doi: 10.7326/M16-2472

Appendix Table 2.

HRs for Consumption of ≥4 Cups per Day Compared With Nondrinkers, Corrected for Different Levels of Confounding by an Unmeasured Dichotomous Confounder Using Sensitivity Analysis*

P1 P0

0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
Γ = 1.2
 0.0 0.79 (0.73–0.85)
 0.1 0.80 (0.74–0.87) 0.79 (0.73–0.85)
 0.3 0.84 (0.77–0.90) 0.82 (0.76–0.88) 0.80 (0.74–0.87) 0.79 (0.73–0.85)
 0.5 0.87 (0.80–0.94) 0.85 (0.79–0.92) 0.84 (0.77–0.90) 0.82 (0.76–0.88) 0.80 (0.74–0.87) 0.79 (0.73–0.85)
 0.7 0.90 (0.83–0.97) 0.88 (0.82–0.95) 0.87 (0.80–0.93) 0.85 (0.78–0.91) 0.83 (0.77–0.90) 0.82 (0.74–0.86) 0.80 (0.74–0.86) 0.79 (0.73–0.85)
 0.9 0.93 (0.88–1.02) 0.91 (0.84–0.98) 0.90 (0.83–0.96) 0.88 (0.81–0.95) 0.86 (0.80–0.93) 0.85 (0.78–0.91) 0.83 (0.77–0.90) 0.82 (0.76–0.88) 0.80 (0.74–0.86) 0.79 (0.73–0.85)
Γ = 1.3
 0.0 0.79 (0.73–0.85)
 0.1 0.81 (0.75–0.88) 0.79 (0.73–0.85)
 0.3 0.86 (0.80–0.93) 0.84 (0.77–0.90) 0.81 (0.75–0.87) 0.79 (0.73–0.85)
 0.5 0.91 (0.84–0.98) 0.88 (0.82–0.95) 0.86 (0.79–0.92) 0.83 (0.77–0.90) 0.81 (0.75–0.87) 0.79 (0.73–0.85)
 0.7 0.96 (0.88–1.03) 0.93 (0.86–1.00) 0.90 (0.83–0.97) 0.88 (0.81–0.94) 0.85 (0.79–0.92) 0.83 (0.77–0.89) 0.81 (0.75–0.87) 0.79 (0.73–0.85)
 0.9 1.00 (0.93–1.08) 0.97 (0.90–1.05) 0.95 (0.87–1.02) 0.92 (0.85–0.99) 0.90 (0.83–0.96) 0.87 (0.81–0.94) 0.85 (0.79–0.91) 0.83 (0.77–0.89) 0.81 (0.75–0.87) 0.79 (0.73–0.85)
Γ = 1.5
 0.0 0.79 (0.73–0.85)
 0.1 0.83 (0.77–0.89) 0.79 (0.73–0.85)
 0.3 0.91 (0.84–0.98) 0.86 (0.80–0.93) 0.82 (0.76–0.89) 0.79 (0.73–0.85)
 0.5 0.99 (0.91–1.06) 0.94 (0.78–1.01) 0.90 (0.82–0.96) 0.86 (0.79–0.92) 0.82 (0.76–0.88) 0.79 (0.73–0.85)
 0.7 1.07 (0.98–1.15) 1.02 (0.94–1.09) 0.97 (0.90–1.04) 0.93 (0.86–1.00) 0.89 (0.82–0.96) 0.85 (0.79–0.92) 0.82 (0.76–0.88) 0.79 (0.73–0.85)
 0.9 1.14 (1.06–1.23) 1.09 (1.01–1.17) 1.04 (0.96–1.12) 1.00 (0.92–1.07) 0.95 (0.88–1.03) 0.92 (0.85–0.99) 0.88 (0.81–0.95) 0.85 (0.78–0.91) 0.82 (0.76–0.88) 0.79 (0.73–0.85)
Γ = 2.0
 0.0 0.79 (0.73–0.85)
 0.1 0.87 (0.80–0.94) 0.79 (0.73–0.85)
 0.3 1.03 (0.95–1.10) 0.93 (0.86–1.00) 0.86 (0.79–0.92) 0.79 (0.73–0.85)
 0.5 1.18 (1.10–1.28) 1.08 (1.00–1.16) 0.99 (0.91–1.06) 0.91 (0.84–0.98) 0.85 (0.78–0.91) 0.79 (0.73–0.85)
 0.7 1.34 (1.24–1.44) 1.22 (1.13–1.31) 1.12 (1.03–1.20) 1.03 (0.95–1.11) 0.96 (0.89–1.03) 0.90 (0.83–0.96) 0.84 (0.78–0.90) 0.79 (0.73–0.85)
 0.9 1.50 (1.39–1.62) 1.36 (1.26–1.47) 1.25 (1.16–1.34) 1.15 (1.07–1.24) 1.07 (0.99–1.15) 1.01 (0.92–1.08) 0.94 (0.87–1.01) 0.88 (0.82–0.95) 0.83 (0.77–0.90) 0.79 (0.73–0.85)

HR = hazard ratio.

*

Values are HR (95% CI). T is the HR for mortality, and U is an unmeasured dichotomous confounder for non– coffee drinkers and for drinkers of ≥4 cups per day. P1 is the proportion exposed to U in the group exposed to ≥4 cups of caffeinated coffee, and P0 is the proportion exposed to U in the group not exposed to coffee. We assume that U is positively associated with coffee consumption, so that P1 ≥ P0. The corrected HR (HRcorrected) is computed as HRobs/([ΓP1 + {1 − P1}]/[ΓP0 + {1 − P0}]), where HRobs is the observed HR (0.79 in this case). Cells with no formatting represent settings where the corrected HR is <1 and is significant, boldface cells represent settings where the CI includes 1, and boldface and italic cells represent settings where the corrected HR is >1 and is significant.